State research center of Virology and biotechnology “Vector” of Rospotrebnadzor plans to begin clinical trials of a vaccine against new coronavirus infection in late June. As told TASS the General Director of the Rinat Maksyutov, for research selected three promising drug.
“In accordance with the approved program of the clinical study will begin on 29 June 2020 after the results of specific activity and safety of vaccines in animals and obtaining permission of the Ministry of health of Russia. While we are working in the framework of our schedule,” said native.
The General Director of “Vector” also said that animal studies were 25 versions of the vaccines. “Three promising formulation was selected as showing the highest efficiency, and also considering technological requirement of large-scale production,” he added.